Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: Environ Sci Technol. 2020 Dec 1;54(24):15946–15957. doi: 10.1021/acs.est.0c03803

Figure 3.

Figure 3

(a). Prevalence of resistance over time among all isolates (n=273) collected on each sample date. An increase in resistance to colistin and gentamicin can be observed after in the introduction of BC testing, introduced at 371 days elapsed. (b). Pearson correlation of resistance prevalence by sample date. Asterisks (*) represent significant relationships (n=20, p<0.05), from strong negative correlation in light grey to strong positive correlation in black, with circle size indicating strength of the relationship. Self-correlations (diagonals) were removed for clarity and exact correlations can be found in Table S5. CC: clindamycin; AMP: ampicillin; ER: erythromycin; TMP: trimethoprim; AZM: azithromycin; NF: nitrofurantoin; AMX: amoxicillin/clavulanic acid; C: chloramphenicol; CL: colistin; CTX: cefotaxime; TET: tetracycline; CIP: ciprofloxacin; GM: gentamicin